600332 Stock Overview
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$28.06 |
| 52 Week High | HK$33.72 |
| 52 Week Low | HK$24.30 |
| Beta | 0.59 |
| 11 Month Change | -3.07% |
| 3 Month Change | -3.47% |
| 1 Year Change | -8.69% |
| 33 Year Change | -4.69% |
| 5 Year Change | -15.58% |
| Change since IPO | 90.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600332 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -0.1% | -0.9% |
| 1Y | -8.7% | -13.3% | 5.4% |
Return vs Industry: 600332 exceeded the CN Healthcare industry which returned -13.3% over the past year.
Return vs Market: 600332 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 600332 volatility | |
|---|---|
| 600332 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600332 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600332's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 28,760 | Hong Li | www.gybys.com.cn |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Fundamentals Summary
| 600332 fundamental statistics | |
|---|---|
| Market cap | CN¥43.12b |
| Earnings (TTM) | CN¥3.42b |
| Revenue (TTM) | CN¥76.39b |
7.8x
P/E Ratio0.4x
P/S RatioIs 600332 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600332 income statement (TTM) | |
|---|---|
| Revenue | CN¥76.39b |
| Cost of Revenue | CN¥63.46b |
| Gross Profit | CN¥12.93b |
| Other Expenses | CN¥9.50b |
| Earnings | CN¥3.42b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.11 |
| Gross Margin | 16.92% |
| Net Profit Margin | 4.48% |
| Debt/Equity Ratio | 35.5% |
How did 600332 perform over the long term?
See historical performance and comparison